Literature DB >> 11224312

Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats.

F. Sams-Dodd1.   

Abstract

d-Amphetamine and phencyclidine (PCP) can induce a model psychosis in humans that resembles schizophrenia. Both drugs reproduce the positive symptoms of schizophrenia, but apparently only PCP mimics the negative symptoms. The purpose of this study was to determine the pharmacological profiles of d-amphetamine and PCP in the social interaction test, and to determine if they have disruptive effects on social behaviour in rats that may be comparable to the social isolation characteristic of negative symptoms. Acute and subchronic (daily for 5 days) administration of d-amphetamine (0.7-22µmol/kg) produced stereotyped behaviour at dosages of 10.4µmol/kg and upwards without any consistent effects on social behaviour. In contrast, acute and subchronic PCP (0.9-29µmol/kg) produced dose-dependent increases in stereotyped behaviour and ataxia as well as dose-dependent reductions in the social behaviour at dosages of 3.6µmol/kg and upwards. Thus, d-amphetamine and PCP had distinct effects on the social behaviour of rats. Both drugs produced stereotyped behaviour and locomotor hyperactivity, but only PCP dose-dependently disrupted social behaviour. This raises the possibility that PCP-induced social isolation in rats corresponds to the social isolation reported in humans under the influence of PCP, and that it can be used as an animal model of negative symptoms.

Entities:  

Year:  1995        PMID: 11224312

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  29 in total

1.  Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats.

Authors:  Thiago Garcia Varga; Juan Guilherme de Toledo Simões; Amanda Siena; Elisandra Henrique; Regina Cláudia Barbosa da Silva; Vinicius Dos Santos Bioni; Aline Camargo Ramos; Tatiana Rosado Rosenstock
Journal:  Psychopharmacology (Berl)       Date:  2021-06-05       Impact factor: 4.530

2.  The group II metabotropic glutamate receptor agonist LY379268 reduces toluene-induced enhancement of brain-stimulation reward and behavioral disturbances.

Authors:  Ming-Huan Chan; Yi-Ling Tsai; Mei-Yi Lee; Astrid K Stoker; Athina Markou; Hwei-Hsien Chen
Journal:  Psychopharmacology (Berl)       Date:  2015-06-06       Impact factor: 4.530

3.  Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice.

Authors:  C Spielewoy; C Roubert; M Hamon; M Nosten-Bertrand; C Betancur; B Giros
Journal:  Behav Pharmacol       Date:  2000-06       Impact factor: 2.293

Review 4.  Animal models of schizophrenia.

Authors:  C A Jones; D J G Watson; K C F Fone
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.

Authors:  R Depoortère; A L Auclair; L Bardin; L Bruins Slot; M S Kleven; F Colpaert; B Vacher; A Newman-Tancredi
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

6.  Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.

Authors:  Maria Sabrina Spano; Liana Fattore; Francesca Cadeddu; Walter Fratta; Paola Fadda
Journal:  Psychopharmacology (Berl)       Date:  2012-08-19       Impact factor: 4.530

7.  The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents.

Authors:  Anna Sławińska; Joanna M Wierońska; Katarzyna Stachowicz; Marcin Marciniak; Magdalena Lasoń-Tyburkiewicz; Piotr Gruca; Mariusz Papp; Magdalena Kusek; Krzysztof Tokarski; Darío Doller; Andrzej Pilc
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

8.  Low dose MK-801 reduces social investigation in mice.

Authors:  Hong Zou; Chenghao Zhang; Qinglian Xie; Manfang Zhang; Junwei Shi; Meilei Jin; Lei Yu
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

9.  Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 × DISC1.

Authors:  Colm M P O'Tuathaigh; Fabio Fumagalli; Lieve Desbonnet; Francesc Perez-Branguli; Gerard Moloney; Samim Loftus; Claire O'Leary; Emilie Petit; Rachel Cox; Orna Tighe; Gerard Clarke; Donna Lai; Richard P Harvey; John F Cryan; Kevin J Mitchell; Timothy G Dinan; Marco A Riva; John L Waddington
Journal:  Schizophr Bull       Date:  2016-09-09       Impact factor: 9.306

10.  Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.

Authors:  Alice Egerton; Lee Reid; Sandie McGregor; Susan M Cochran; Brian J Morris; Judith A Pratt
Journal:  Psychopharmacology (Berl)       Date:  2008-04-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.